Study Details

Back
Study ID 1517-CL-0613
Study Title A Phase 3, Randomized, Open-Label, Active-Controlled Study to Evaluate the Efficacy and Safety of Roxadustat in the Maintenance Treatment of Anemia in End Stage Renal Disease Subjects on Stable Dialysis
Clinicaltrials.gov Identifier NCT02278341
Compound Name ASP1517 / roxadustat
Medical Indication or Disease Anemia with chronic kidney disease
Study Sponsor Astellas Pharma Europe B.V.
Collaborator FibroGen
Study Start Date 21-Nov-2014
Study Completion Date 06-Jul-2018
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
English